On this page:OverviewKey papers
ScholarIQanswers from OpenAlex

Molecular Cancer Therapeutics

JournalCitation impact & published research

Molecular Cancer Therapeutics is a journal indexed in ScholarIQ from OpenAlex.

How many works does Molecular Cancer Therapeutics have?

ScholarIQindexed works

Molecular Cancer Therapeutics has 12,741 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Molecular Cancer Therapeutics have?

ScholarIQcitation count

Molecular Cancer Therapeutics has 372,106 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Molecular Cancer Therapeutics?

ScholarIQh-index

Molecular Cancer Therapeutics has an h-index of 218 in OpenAlex.

What is the OpenAlex record for Molecular Cancer Therapeutics?

ScholarIQopenalex

The OpenAlex for Molecular Cancer Therapeutics is on the source record.

What are the most-cited papers on Molecular Cancer Therapeutics?

ScholarIQmost cited works
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Molecular Cancer Therapeutics. 20172,408 CitationsOPEN ACCESS
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel, Razelle Kurzrock
Molecular Cancer Therapeutics. 20152,356 Citations
Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
Junko Murai, Shar-yin N. Huang, Amèlie Renaud, Yiping Zhang, Jiuping Ji, Shunichi Takeda, Joel Morris, Beverly A. Teicher, James H. Doroshow, Yves Pommier
Molecular Cancer Therapeutics. 2013766 CitationsOPEN ACCESS
Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial
Huw D. Thomas, Christopher Calabrese, Michael A. Batey, Stacie Canan, Zdeněk Hostomský, Suzanne Kyle, Karen A. Maegley, David R. Newell, Donald J. Skalitzky, Lan-Zhen Wang, Stephen E. Webber, Nicola J. Curtin
Molecular Cancer Therapeutics. 2007304 Citations
Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
Bo Zhai, Fengli Hu, Xian Jiang, Jun Xu, Dali Zhao, Bing Liu, Shangha Pan, Xuesong Dong, Gang Tan, Zheng Wei, Haiquan Qiao, Hongchi Jiang, Xueying Sun
Molecular Cancer Therapeutics. 2014283 Citations

Related on ScholarIQ

470M+ articles · 14-day free trial